KRYS Earnings

Quarterly EPS
$0.95
Q3 2024
$1.58
Q4 2024
$1.24
Q1 2025
$1.33
Q2 2025
$2.74
Q3 2025
$1.77
Q4 2025
$1.91
Q1 2026
$1.85
Q2 2026
Latest Revenue119.2M
Latest Net Income54.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.85119.2M54.8M+24.1%+39.1%
Q1 2026$1.91116.4M55.9M+31.9%+54.0%
Q4 2025$1.77107.1M51.4M+17.5%+12.0%
Q3 2025$2.7497.8M79.4M+16.6%+188.4%
Q2 2025$1.3396.0M38.3M+36.6%+146.3%
Q1 2025$1.2488.2M35.7M+94.9%+4,033.3%
Q4 2024$1.5891.1M45.5M+116.3%+409.7%
Q3 2024$0.9583.8M27.2M+879.9%-67.0%
Q2 2024$0.5470.3M15.6M
Q1 2024$0.0345.3M932.0K
Q4 2023$0.3142.1M8.7M
Q3 2023$2.888.6M80.7M
Krystal Biotech (KRYS) — Earnings